Mein Warenkorb

FGF19

FGF19 Molekülinformation

Englischer NameFibroblast growth factor 19Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2Target-AliasFGF-19
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameFibroblast growth factor 19
Target-AliasFGF-19
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

FGF19 Produktliste

  • Attribut

    Protein (3)

  • Produktbibliothek

    Online (3)

  • Spezies

    Human (3)

  • Etikett

    Fc Tag (1)His Tag (1)Mouse IgG Fc Tag (1)

  • Marker

    Unconjugated (3)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
Human
E. coli
Human FGF19 Protein, His Tag (BLI verified)
In den Warenkorb legen
Human
HEK293
Human FGF19 Protein, Fc Tag
In den Warenkorb legen
Human
HEK293
Human FGF19 Protein, Mouse IgG2a Fc Tag
In den Warenkorb legen
Gesamtmenge3
  • 1

FGF19 Molekülhintergrund

Fibroblast growth factor (FGF)19 is the first members of a new subfamily of FGFs and could act as hormones. During fetal life, FGF15/19 is involved in organogenesis, affecting the development of the ear, eye, heart, and brain. FGFs–FGFRs are involved in regulation of many biological processes such as embryonic development, cell proliferation, differentiation, and tissue repair. The dysregulation of FGF–FGFR was observed in different types of diseases, disorders, and cancers. Notably, aberrant expression of FGF19/FGFR4 contributes to Hepatocellular Carcinoma progression.

FGF19 Molekülalias

FGF19,FGF-19,Fibroblast growth factor 19

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
AldaferminM-70; NGM-282; M70; NGM282Phase 2 ClinicalNGM Biopharmaceuticals IncBile acid malabsorption (BAM); Cholangitis, Sclerosing; Constipation; Diabetes Mellitus; Diarrhea; Fibrosis; Hepatic Insufficiency; Irritable Bowel Syndrome; Liver Cirrhosis, Biliary; Malabsorption Syndromes; Metabolic Dysfunction-Associated Steatotic Liver Disease; Renal Insufficiency
Details
HH-009Phase 1 ClinicalHuahui Health LtdNeoplasms; Solid tumours
Details

Produktrezensionen

  • M***i2023-02-08
    1Menschen mögen
    Awesome.The product quality was good ,and great technical service and I received the product on time.
  • Molekülinformation
  • Produktliste
  • Produktrezensionen
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns